Encompass Health Corporation
EHC • NYSE
Encompass Health Corporation is a medical - care facilities company in the healthcare sector trading on NYSE, led by CEO Mark J. Tarr, with a market cap of $9.7B.
CEOMark J. Tarr
Next Earnings
Upcoming earnings announcement for Encompass Health Corporation
Date
Thursday, April 23, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.51
Revenue Estimate
$1.6B
Earnings History
Past 12 earnings reports for Encompass Health Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $1.46Est: $1.30 | +12.3% | $1.5BEst: $1.5B | +0.3% |  10-K |
| Oct 29, 2025 | Q3 2025 | $1.23Est: $1.19 | +3.4% | $1.5BEst: $1.5B | -0.2% | 10-Q |
| Aug 4, 2025 | Q2 2025 | $1.40Est: $1.21 | +15.7% | $1.5BEst: $1.4B | +2.1% | 10-Q |
| Apr 24, 2025 | Q1 2025 | $1.37Est: $1.19 | +15.1% | $1.5BEst: $1.4B | +1.7% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $1.17Est: $1.03 | +13.6% | $1.4BEst: $1.4B | +1.7% | 10-K |
| Oct 28, 2024 | Q3 2024 | $1.03Est: $0.94 | +9.6% | $1.4BEst: $1.3B | +1.6% | 10-Q |
| Aug 5, 2024 | Q2 2024 | $1.11Est: $1.01 | +9.9% | $1.3BEst: $1.3B | +0.1% | 10-Q |
| Apr 24, 2024 | Q1 2024 | $1.12Est: $0.94 | +19.1% | $1.3BEst: $1.3B | +3.6% | 10-Q |
| Feb 7, 2024 | Q4 2023 | $0.95Est: $0.82 | +15.9% | $1.2BEst: $1.2B | +0.6% | 10-K |
| Oct 26, 2023 | Q3 2023 | $0.86Est: $0.77 | +11.7% | $1.2BEst: $1.2B | +1.4% | — |
| Aug 1, 2023 | Q2 2023 | $0.95Est: $0.74 | +28.4% | $1.2BEst: $1.2B | +2.0% | 10-Q |
| Apr 27, 2023 | Q1 2023 | $0.88Est: $0.70 | +25.7% | $1.2BEst: $1.1B | +1.8% | — |